ACR Convergence 2025| Video: Rheum for Everyone, Episode 26—Ableism

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: methotrexate

Doc Reflects on Rheumatology’s Progress During Past 50 Years

Alan. H. Mallace, MD, FACR  |  December 11, 2025

Alan. H. Mallace, MD, FACR, looks back at a half-century of practicing rheumatology & looks ahead to what the future might hold for fellows starting out today.

Filed under:CareerEducation & TrainingOpinionSpeak Out Rheum Tagged with:fellowshipHistoryMentorshipprednisone

B Original: B Cells, Non-Invasive Biomarkers & More

Jason Liebowitz, MD, FACR  |  December 8, 2025

Experts discussed how aspects of the immune system other than B cells play a role in lupus, including mitochondria in red blood cells, proteins present in urine and more.

Filed under:ConditionsEULAR/OtherMeeting ReportsSystemic Lupus Erythematosus Tagged with:B cellsEULAR 2025Lupus nephritis supplementmitochondriaskinSLESLE Resource Centersystemic lupus erythematosus (SLE)

Insights into SLE & Lupus Nephritis From the 2025 Review Course

Jason Liebowitz, MD  |  December 7, 2025

Review expert strategies & clinical pearls for managing SLE & lupus nephritis. Get therapeutic updates from the ACR’s 2025 Review Course.

Filed under:ACR ConvergenceConditionsMeeting ReportsPediatric ConditionsSystemic Lupus Erythematosus Tagged with:belimumabDr. Stacy ArdoinLupus Low Disease-Activity State (LLDAS)Lupus nephritis supplementneuropsychiatric lupusobinutuzumabPediatric RheumatologyTreat-to-Target

How Rheumatologists Can Integrate Shared Decision Making into Clinical Practice

Mary Beth Nierengarten  |  November 19, 2025

Experts identify barriers to shared decision making in rheumatology & offer actionable tools to integrate SDM into practice for better patient outcomes.

Filed under:ACR ConvergenceConditionsMeeting ReportsPatient PerspectiveResearch RheumRheumatoid Arthritis Tagged with:ACR Convergence 2025ACR Convergence 2025 - RAadherencehealth literacypatient outcomespatient-centered carephysician-patient communicationshared decision making

Experts Discuss Draft of New JIA Guideline

Thomas R. Collins  |  November 18, 2025

At this ACR Convergence session, experts provided an overview of the new ACR guideline for juvenile idiopathic arthritis.

Filed under:ACR ConvergenceClinical Criteria/GuidelinesConditionsMeeting ReportsPediatric Conditions Tagged with:ACR Convergence 2025JIA GuidelineJIA-associated uveitisJIA-associated uveitis guidelinejuvenile idiopathic arthritis (JIA)pediatric arthritisUveitis

New Insights into the Management of Interstitial Lung Disease

Kurt Ullman  |  November 18, 2025

Discover the latest ILD management strategies for RA, SSc & myositis, plus expert guidance on pregnancy & defining progressive pulmonary fibrosis.

Filed under:ACR ConvergenceBiologics/DMARDsConditionsDrug UpdatesMeeting ReportsResearch Rheum Tagged with:ACR Convergence 2025Drug UpdatesInterstitial Lung Diseasepregnancy

Approaches to the Management of SLE During Pregnancy

Ruth Jessen Hickman, MD  |  November 14, 2025

At this ACR Convergence 2025 session, experts discussed disease management considerations to optimize outcomes in pregnant patients with SLE.

Filed under:ACR ConvergenceMeeting ReportsSjögren’s DiseaseSystemic Lupus ErythematosusSystemic Sclerosis Tagged with:ACR Convergence 2025ACR Convergence 2025 - LNLupuspatient carepregnancySjögren's Diseasesystemic lupus erythematosus (SLE)Treatment

Advances in Giant Cell Arteritis

Philip Seo, MD, MHS  |  November 14, 2025

Dr. Philip Seo highlights the latest research into the assessment and treatment of giant cell arteritis presented during ACR Convergence 2025.

Filed under:ACR ConvergenceConditionsMeeting ReportsVasculitis Tagged with:AAV FocusRheumACR Convergence 2025ANCA-Associated Vasculitisgiant cell arteritis (GCA)GlucocorticoidsimagingMagnetic resonance imaging (MRI)taperingupadacitinib

ACR Releases New Guideline for Management of SLE at ACR 2025

Mithu Maheswaranathan, MD  |  November 14, 2025

Updating the last iteration in 1999, the new ACR Guideline for Management of SLE was unveiled at ACR Convergence 2025, providing rheumatologists an organ-based approach for therapeutic options for specific lupus manifestations.

Filed under:ACR ConvergenceClinical Criteria/GuidelinesConditionsGuidanceMeeting ReportsSystemic Lupus Erythematosus Tagged with:ACR Convergence 2025BiologicsClinical Practice GuidelinesLupussystemic lupus erythematosus (SLE)

New Rheumatoid Arthritis Risk Stratification Criteria Released

Ruth Jessen Hickman, MD  |  November 10, 2025

New EULAR/ACR criteria help stratify RA risk in patients with arthralgia. Learn how these criteria guide earlier interventions & improve trial rigor.

Filed under:Clinical Criteria/GuidelinesConditionsEULAR/OtherGuidanceResearch RheumRheumatoid Arthritis Tagged with:ACPAarthralgiasC-reactive proteinearly RAPreclinical Rheumatoid ArthritisRA Resource CenterRheumatoid FactorRisk Factorsrisk stratification

  • « Previous Page
  • 1
  • …
  • 4
  • 5
  • 6
  • 7
  • 8
  • …
  • 109
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences